583 related articles for article (PubMed ID: 8776360)
1. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
2. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
3. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
Singh S; Reddy DC; Pandey SS
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
[TBL] [Abstract][Full Text] [Related]
4. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
5. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
6. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
7. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
[TBL] [Abstract][Full Text] [Related]
9. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
Fleischer AB; Feldman SR
Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
[TBL] [Abstract][Full Text] [Related]
10. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Bovenschen HJ; Gerritsen WJ; van Rens DW; Seyger MM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study.
Kwon HB; Choi Y; Kim HJ; Lee AY
J Drugs Dermatol; 2013 Apr; 12(4):e63-7. PubMed ID: 23652908
[TBL] [Abstract][Full Text] [Related]
12. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
Nolting S; Hagemeier HH
Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
16. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
17. The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis.
Segaert S; Ropke M
J Drugs Dermatol; 2013 Aug; 12(8):e129-37. PubMed ID: 23986173
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
19. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
20. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
Miller JJ; Roling D; Margolis D; Guzzo C
J Am Acad Dermatol; 1999 Oct; 41(4):546-9. PubMed ID: 10495373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
